Market research
002728.SHE Teyi Pharmaceutical Group Co.,Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 5B
- P/E ratio
- 63.57
- Analyst target
- 13.93
- Dividend yield
- 1.6%
- Beta
- 1.35
Community
Investor discussion
1 comment
Sign in to join the 002728.SHE discussion.
5 years, 5 months ago
Teyi Pharmaceutical Group Co.,Ltd is currently in a long term uptrend where the price is trading 7.0% above its 200 day moving average.
From a valuation standpoint, the stock is 64.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.
Teyi Pharmaceutical Group Co.,Ltd's total revenue sank by 43.3% to $133M since the same quarter in the previous year.
Its net income has dropped by 96.3% to $1M since the same quarter in the previous year.
Finally, its free cash flow grew by 13.2% to $23M since the same quarter in the previous year.
Based on the above factors, Teyi Pharmaceutical Group Co.,Ltd gets an overall score of 3/5.